Antimicrobial blue light: A ‘Magic Bullet’ for the 21st century and beyond?
Authors:
- 18 November 2021
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 180, 114057
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War
- Air Force Office of Scientific Research (FA9550-17-1-0277)
- American Society for Laser Medicine and Surgery (BS.01.20)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/10851-4)
- National Institutes of Health (R01AI123312)
This publication has 102 references indexed in Scilit:
- The refusal of the Society to accept antibiotic toxicity: missing opportunities for therapy of severe infectionsClinical Microbiology and Infection, 2016
- Antimicrobial blue light inactivation ofCandida albicans:In vitroandin vivostudiesVirulence, 2016
- Antimicrobial blue light inactivation ofPseudomonas aeruginosaby photo-excitation of endogenous porphyrins: In vitro and in vivo studiesLasers in Surgery and Medicine, 2016
- Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo StudiesThe Journal of Infectious Diseases, 2016
- Magic bullet: Paul Ehrlich, Salvarsan and the birth of venereologySexually Transmitted Infections, 2015
- Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problemTherapeutic Advances in Drug Safety, 2014
- A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the FutureFrontiers in Microbiology, 2010
- Paul Ehrlich's Magic BulletsNew England Journal of Medicine, 2004
- The Nobel ChroniclesThe Lancet, 1999
- Address in Pathology, ON CHEMIOTHERAPY: Delivered before the Seventeenth International Congress of MedicineBMJ, 1913